Daman to host 4th national congress of drugs control officers to strengthen India's public health regulations: Our Bureau, Chennai Friday, July 10, 2026, 13:30 Hrs [IST] The 4th A ...

Piramal Pharma stated that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville manufacturing facility and the inspection has now been successfully closed by the US FDA.

LPU researchers develop novel ayurvedic formulation for PCOS management: Our Bureau, Mumbai Friday, July 10, 2026, 17:40 Hrs [IST] Researchers from the School of Pharmaceutical Sc ...

Lynk Pharmaceuticals doses first patient in phase II trial of LNK01004 ointment for vitiligo: Shanghai Friday, July 10, 2026, 18:00 Hrs [IST] Lynk Pharmaceuticals Co Ltd, a clinic ...

Centre postpones foundation stone laying ceremony of ICMR CHAMP: Our Bureau, New Delhi Friday, July 10, 2026, 15:45 Hrs [IST] The Union ministry of health has informed that the fo ...

Corten Capital and Ampersand acquire Beacon Intelligence to accelerate growth in life sciences R&D intelligence: Toronto Friday, July 10, 2026, 17:00 Hrs [IST] Corten Capital and ...

Sino Biopharma’s subsidiary, CTTQ further deepens the exclusive strategic collaboration with GSK: Hong Kong Friday, July 10, 2026, 16:00 Hrs [IST] Sino Biopharmaceutical Limited ...

UK MHRA approves the use of UK-donor plasma for five high-priority plasma-derived medicinal products: United Kingdom Friday, July 10, 2026, 14:00 Hrs [IST] Following an extensive ...

AstraZeneca & Ionis’ phase III trial for Wainua in patients with transthyretin-mediated amyloid cardiomyopathy fails to meet primary efficacy endpoint: Cambridge, UK Friday, Jul ...

Price growth and new launches outpace volume gains as Indian pharma market expands 11.6 per cent in June quarter: Our Bureau, Chennai Friday, July 10, 2026, 14:30 Hrs [IST] The st ...

Centre amends D&C Rules to mandate sale of high alcohol-containing drugs only through prescription: Our Bureau, New Delhi Friday, July 10, 2026, 15:10 Hrs [IST] In a measure to st ...

Keenova Therapeutics plc, a leading US-focused branded therapeutics company, announced positive results from its phase 3 clinical trial of Xiaflex (collagenase clostridium histolyticum) for the ...